Angle Share Discussion Threads

[5oletrader] 26/4/2024 15:52

RISKs of SECOND primary cancers among 584,965 female and male BREAST cancer survivors in England - a 25 YEAR retrospective cohort STUDY.Https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00069-3/fulltext- "It's IMPORTANT for us to understand to what extent having one type of cancer puts you at RISK of a SECOND cancer at a different site. The female and male BREAST cancer survivors whose data we studied were at INCREASED RISK of a number of SECOND cancers. KNOWING this can HELP inform conversations with their care teams to look out for SIGNS of potential new cancers."Https://www.cam.ac.uk/research/news/study-highlights-increased-risk-of-second-cancers-among-breast-cancer-survivors-25 YEARS of STRONG EVIDENCE!!!Reaffirms the NEED for regular screening + ANGLE having FDA approval in BREAST cancer - could it mean tests 'FOR PATIENTS' are in the not too distant future?25 years of evidence says we need it!

[donald pond] 26/4/2024 10:02

Five trades reported as sells which look like a cunningly disguised rollover

[robizm] 26/4/2024 10:00

Until the sell on the spike pack start selling. They have bought at 13.5p so soon they will go for the profit then rinse and repeat.

[kirk 6] 26/4/2024 09:58

This is going to rocket

[citys2874] 26/4/2024 09:37

in the top 25 gainers on the leaderboard moving up nicely and mms ready to tick up again

[washingmachine] 26/4/2024 09:26

Wait for results imo

[zeus19] 26/4/2024 09:25

Thats too much information for her tiny brain

[5oletrader] 26/4/2024 09:13

@699 maybe highlight the caveat to this 'tiny deal' - as the below means nothing does it:• The collaboration gives ANGLE the POTENTIAL to EXPAND their services in oncology trials. The initial phase of the contract is valued at £150,000, but it holds SUBSTANTIAL POTENTIAL due to the possibility of implementing a new assay in NUMEROUS cancer TRIALS involving AstraZeneca. • Furthermore, the collaboration includes the development of assays for examining proteins on cancer cells across multiple trials, with POTENTIAL EARNINGS of £2,000 per time point in over 460 trials involving 140,000 patients.• ?140,000 patients x £2,000 = £280M• ?£280M x 3 time points = £840M-In effect ANGLE have opened the door to a 840 MILLION QUID BUSINESS OPPORTUNITY with just AstraZeneca. Want to do the maths on EISAI trials too?

[boris cobaka] 26/4/2024 09:06

Results due soonish?

[citys2874] 26/4/2024 09:02

In the top 40 gainers now on the leaderboard and mms are ready to tick up once again

[donald pond] 26/4/2024 09:01

Looking interesting here. Buys coming in, needs more volume of course

[citys2874] 26/4/2024 09:01

strong buying coming in now and gaining good momentum can we see a happy Friday and see this in the high teens this afternoon

[zeus19] 26/4/2024 08:40

Suppliers? Again just shows how uneducated you are

[bones699] 26/4/2024 07:57

AZ has thousands of suppliers..a £150k tiny deal doesn't cut the mustard ffs!

Shell oil has a massive market cap doesn't mean to say they will buy my car any day soon because it runs on petrol lol!

[muffster] 26/4/2024 07:27

Wonderful partnership announced withAstrazeneca a fast growing pharmaceutical company.News on Astrazeneca from ProactiveAs it stands, Astra's market capitalisation is now around £184.61 billion, edging out Shell's £184.57 billion.The pharma giant has enjoyed a spate of upgrades in 2024, with Deutsche Bank analysts highlighting its innovation and growth strategy, and its approach to expansion via bolt-on acquisitions.....

[bones699] 26/4/2024 07:18

An RNS for a measily £150k...really?

Still need to find c.£6m of revenues very soon otherwise its cash placement time!

[danwaits] 26/4/2024 07:10

Interesting;
hxxps://www.theguardian.com/society/2024/apr/26/cancer-mrna-vaccine-melanoma-trial

[arthur_lame_stocks] 25/4/2024 13:03

'Among the main criticisms from AIM advisers – known as nomads – is that the cost of listing for young, dynamic companies is far too high, about £500,000 at the last count, and that regulations are too tight and onerous.'

Are they joking?

[htrocka2] 25/4/2024 12:40

Maybe the 'partners' will come here?

[fhmktg] 25/4/2024 12:17

Sad to see what looks like blatant suppression of the share price after such encouraging announcements.
UK seems to continually fail to support such an innovative Company in such a demanding therapy area.
AN could be well advised to seek a more enlightened overseas partner.

[jelenko] 25/4/2024 10:54

Sad sad individual. Nowhere to be seen yesterday though!!

[zeus19] 25/4/2024 09:55

This just shows how unintelligent you are

[inaminute] 25/4/2024 09:54

All you need to read in that statement is ALOT. The best indicator going of a halfwit

[bones699] 25/4/2024 09:52

My projected price target back to sub 12p!

Alot of hype in yesterday's RNS only one number matters £150k so just another £5.75m to find Newland before the inevitable cash placement following the diasterous financials to be released and chucked on the nearest bonfire!